Skip to main content

Table 3 Distribution of antimicrobials used for Ventilator-Associated Pneumonia treatment in studied ICUs, 2013–2015, no data: 56 (27%)

From: Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015

Antimicrobial agents ATC codes Antibiotic N (%)
Beta-lactam antibacterials, penicillins (16.1% of all antimicrobials) 24 (100)
 Penicillins, with extended spectrum J01CA J01CA12 Piperacillin 5 (20.8)
 Beta lactamase resistant penicillins J01CF J01CF02 Cloxacillin 5 (20.8)
 Combinations of penicillins incl. Beta-lactamase inhibitors J01CR J01CR02 Amoxicillin and enzyme inhibitor 14 (58.3)
Other beta-lactam antibacterials (37.6% of all antimicrobials) 56 (100)
 Second-generation cephalosporins J01DC J01DC03 Cefamandole 1 (1.8)
 Third-generation cephalosporins J01DD J01DD02 Ceftazidime 3 (5.4)
JO1DD04 Ceftriaxone 4 (7.1)
JO1DD01 Cefotaxime 21 (37.5)
 Carbapenems J01DH J01DH02 Meropenem 16 (28.6)
J01DH51 Imipenem and enzyme inhibitor 11 (19.6)
Other antibacterials (18.8% of all antimicrobials) 28 (100)
 Glycopeptide antibacterials J01XA J01XA01 Vancomycin 6 (21.4)
J01XA02 Teicoplanin 1 (3.6)
 Polymyxins J01XB J01XB01 Colistin 21 (75.0)
Sulfonamides and trimethoprim (4.0% of all antimicrobials) 6 (100)
 Combinations of sulfonamides and trimethoprim, incl. Derivatives J01EE J01EE01 Sulfamethoxazole and trimethoprim 6 (100.0)
Aminoglycoside antibacterials (10.7% of all antimicrobials) 16 (100)
 Aminoglycosides J01GB06 Amikacin 16 (100.0)
Quinolone antibacterials (9.4% of all antimicrobials) 14 (100)
 Quinolone J01MA J01MA02 Ciprofloxacin 7 (50.0)
J01MA12 Levofloxacin 7 (50.0)
Macrolides, lincosamides and streptogramines (1.3% of all antimicrobials) 2 (100)
 Lincosamides J01FF J01FF01 Clindamycin 2 (100.0)
Antimycotics for systemic use (2.0% of all antimicrobials) 3 (100)
 Triazole derivatives J02AC01 Fluconazole 3 (100.0)
Total 149 (100.0)